Fenbendazole for Ovarian Cancer: Evidence and Safety
Fenbendazole is a veterinary antiparasitic drug attracting growing interest among ovarian cancer patients. This article reviews the 2024 preclinical findings, documented liver injury risks, and interaction concerns with standard chemotherapy that every patient should discuss with their oncologist.
